Clinical Adoption Arkstone's Expert-in-the-Loop ML/AI clinical decision platform offers a ready-to-integrate antimicrobial stewardship and infectious disease management solution, presenting strong prospects with hospital systems and EHR vendors.

Global Expansion Ongoing international partnerships and PE-backed growth signal a scalable expansion model; pursue regional distributors and health tech integrators to extend adoption into new markets.

Cost Synergy The addition of drug cost information to OneChoice alongside antimicrobial stewardship leadership creates upsell opportunities with procurement teams, formulary committees, and payer programs seeking cost-effective guidance.

Academic Partnerships Proven collaborations with UNG show a pathway for pilots and co-development with universities and research centers, expanding proof points and academic sponsorship channels.

Growth Capital Acquisition by Archimed highlights access to growth capital and scalability, enabling enterprise deployments and multi-site contracts with potential long-term partnerships.